world
Johnson & Johnson Adds Four Drugs to TrumpRx Discount Site Following Voluntary Agreement
Johnson & Johnson will begin marketing four medications on the Trump administration's TrumpRx website on Friday. The move follows a voluntary agreement announced in January that provides Medicaid access to affordable prescriptions in exchange for tariff exemptions. The addition more than doubles the number of drugs on the site since its February launch.
Apr 25, 2:30 PM·1m read2 sources
medium.comAudio version
Tap play to generate a narrated version.
Developing·Limited corroboration so far. This page will refresh as more sources emerge.
Johnson & Johnson will start marketing four medications on the Trump administration's TrumpRx website on Friday, @CBSNews reported. The pharmaceutical company announced in January that it entered into a voluntary agreement with the Trump administration.
The voluntary agreement provides Medicaid access to affordable prescriptions and marketing of Johnson & Johnson drugs on TrumpRx in exchange for exemption from the president's tariff agenda.
One drug offered on the TrumpRx site is metformin, a prescription to treat Type 2 diabetes. Another drug offered on the TrumpRx site is metformin extended relief. Another drug offered on the TrumpRx site is Invokana, a diabetes medication.
Another drug offered on the TrumpRx site is Xarelto, a blood thinner. Johnson & Johnson agreed to invest $55 billion in research and production sites in Pennsylvania and North Carolina. The TrumpRx site first launched in February.
The addition of Johnson & Johnson pharmaceuticals has more than doubled the number of drugs featured on the TrumpRx site since its launch. Prescription drug prices on the TrumpRx site are available to patients who are uninsured or whose insurance does not cover the drugs and who must pay the full list price out of pocket. TrumpRx is the White House's discounted pharmaceutical site.
